Compare Nuvalent Inc (NUVL) vs Raymond James Financial, Inc. (RJF) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuvalent Inc vs Raymond James Financial, Inc. — how do they compare? Nuvalent Inc trades at $123.96 (market cap $9.81B), while Raymond James Financial, Inc. trades at $168.25 (market cap $32.80B). The key difference: Raymond James Financial, Inc. is far larger — about 3.3× Nuvalent Inc's market cap, and Raymond James Financial, Inc. pays a 1.28% dividend while Nuvalent Inc pays none. Which is the better fit depends on your goals.
| NUVL | RJF | |
|---|---|---|
Market Cap | $9.81B | $32.80B |
Sector | Technology | Financials |
52-Week High | $123.96 | $176.43 |
52-Week Low | $72.16 | $140.89 |
Enterprise Value | $8.52B | — |
Dividend Yield | — | 1.28% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nuvalent Inc
Nuvalent, Inc. is a clinical-stage oncology company focused on creating precisely targeted therapies for patients with cancers driven by specific gene mutations. The company leverages a deep understanding of structural biology and medicinal chemistry to design novel small-molecule kinase inhibitors to overcome resistance mechanisms in advanced solid tumors. Nuvalent is committed to developing its pipeline of candidates to address high unmet needs in the treatment of various cancers.
Read more on NUVL →About Raymond James Financial, Inc.
Raymond James Financial is a financial holding company whose major operations include wealth management, investment banking, asset management, and commercial banking. The company has more than 14,000 employees and supports more than 5,000 independent contractor financial advisors across the United States, Canada, and the United Kingdom. Approximately 90% of the company's revenue is from the U.S. and 70% is from the company's wealth-management segment.
Read more on RJF →
